New analysis suggests that further trials of vitamin D have little chance of showing health benefits

January 23, 2014

A new study concludes that evidence is lacking for substantial health benefits of vitamin D—and that results of several multi-million-dollar trials currently underway are unlikely to alter this view.

The study, published in The Lancet Diabetes & Endocrinology, examines existing from 40 randomised controlled trials – the gold standard for proving cause and effect – and concludes that vitamin D supplementation does not prevent heart attack, stroke, cancer, or bone fractures in the general population by more than 15%. Thus, vitamin D , which are taken by nearly half of US adults, probably provide little, if any, health benefit.

Previous observational studies have shown that vitamin D deficiency is strongly associated with poor health and early death. However, evidence from now indicates that this association is not causal – that is, that supplementation is not likely to have any benefit. In line with this idea, the results of a large systematic review by Philippe Autier and colleagues, published in December 2013, also in The Lancet Diabetes & Endocrinology, suggested that low levels of vitamin D are a consequence, not a cause, of ill health.

In the new study, Dr Mark Bolland of the University of Auckland, New Zealand, and colleagues build on this evidence using several types of meta-analysis, including a 'futility analysis', which predicts the potential of future study results to sway existing evidence. The results of their study indicate that the effect of vitamin D, taken with or without calcium, on heart attack, stroke, cancer, and total fracture lies below a 'futility threshold'. For hip fracture, the results of some trials even suggested increased risk with vitamin D supplementation. The authors' analysis of whether vitamin D supplementation can reduce mortality by 5% or more was inconclusive.

Writing in a linked Comment, Professor Karl Michaëlsson, of Uppsala University in Sweden, concludes that, "Without stringent indications—i.e. supplementing those without true vitamin D insufficiency—there is a legitimate fear that vitamin D supplementation might actually cause net harm."

More information: www.thelancet.com/journals/landia/article/PIIS2213-8587(13)70212-2/abstract

Related Stories

Vitamin D with calcium shown to reduce mortality in elderly

June 15, 2012

A study recently published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM) suggests that vitamin D—when taken with calcium—can reduce the rate of mortality in seniors, therefore ...

USPSTF: Vitamin D, calcium supplements don't prevent fx

February 26, 2013

(HealthDay)—For non-institutionalized postmenopausal women, the U.S. Preventive Services Task Force (USPSTF) recommends against daily supplementation with ≤400 IU of vitamin D3 and ≤1,000 mg of calcium for primary prevention ...

Who benefits from vitamin D?

August 13, 2013

Studying the expression of genes that are dependent on vitamin D makes it possible to identify individuals who will benefit from vitamin D supplementation, shows a University of Eastern Finland study published recently in ...

Can vitamin B supplements help stave off stroke?

September 18, 2013

New evidence suggests that taking vitamin B supplements may help reduce the risk of stroke. The research appears in the September 18, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Recommended for you

Can four fish oil pills a day keep the doctor away?

July 7, 2015

Fish oil is one of the most popular dietary supplements in the U.S. because of the perceived cardiovascular benefits of the omega-3 it contains. However, scientific findings on its effectiveness have been conflicting. New ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.